Traditional agriculture remains tethered to volatile weather patterns and land availability. By transitioning coffee production to plant cell culture, companies like Coffeesai can bypass these environmental constraints. Brevel’s platform introduces light into the closed fermentation process, a departure from standard dark fermentation that allows for precise control over cell metabolism. This method triggers specific biological responses, boosting the yield of valuable natural compounds that define coffee’s sensory characteristics.

Brevel recently secured a USD 1 million grant from the Israel Innovation Authority to adapt this infrastructure for plant cell-culture applications. According to CEO Yonatan Golan, the platform has already demonstrated high-density, semi-continuous growth in trials. Coffeesai is currently evaluating these results to determine if the technology can reliably scale to commercial levels. Beyond this partnership, Brevel is extending its reach to other sectors, including collaborations with US-based Ayana Bio and various cocoa cell-culture startups, as it moves to prove the viability of light-driven biology at a 5,000-liter scale.